¼¼°èÀÇ Çǽ¬ ¿ÀÀÏ EPA ¹× DHA ½ÃÀå : ¿¹Ãø(-2031³â)
Global Fish Oil EPA and DHA Market Insights, Forecast to 2031
»óǰÄÚµå : 1754858
¸®¼­Ä¡»ç : QYResearch
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,900 £Ü 6,718,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,350 £Ü 10,077,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ³»¿ëÀÇ ÅØ½ºÆ® µîÀ» Copy & Paste ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 9,800 £Ü 13,436,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è Çǽ¬ ¿ÀÀÏ EPA ¹× DHA ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£(2025-2031) µ¿¾È 3.37%ÀÇ CAGR·Î 2024³â 16¾ï 2,490¸¸ ´Þ·¯¿¡¼­ 2031³â 20¾ï 2,084¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ì±¹ ¹× ij³ª´ÙÀÇ ¾îÀ¯ EPA ¹× DHA ½ÃÀå ±Ô¸ð´Â 2024³â 5¾ï 8,545¸¸ ´Þ·¯¿¡¼­ 2031³â 6¾ï 8,337¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2031³â±îÁö ¿¹Ãø ±â°£ µ¿¾È 2.57%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áß±¹ÀÇ ¾îÀ¯ EPA ¹× DHA ½ÃÀå ±Ô¸ð´Â 2024³â 3¾ï 7,356¸¸ ´Þ·¯¿¡¼­ 2031³â¿¡´Â 5¾ï 2,495¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2031³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 5.03%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯·´ÀÇ ¾îÀ¯ EPA ¹× DHA ½ÃÀå ±Ô¸ð´Â 2024³â 3¾ï 5,813¸¸ ´Þ·¯¿¡¼­ 2031³â¿¡´Â 4¾ï 2,879¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2031³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 2.80%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Çǽ¬ ¿ÀÀÏ EPA ¹× DHAÀÇ ¼¼°è ÁÖ¿ä Á¦Á¶¾÷ü·Î´Â KD Pharma, Croda, BASF, Yuwang Pharma, GC Rieber VivoMega, Pelagia(EPAX), Golden Omega, TASA, KinOmega Biopharm, Omega Protein, Huatai Phrama, AlaskOmega(Wiley Companies), Jiangsu Auqi Marine Biotechnology, Sinomega Biotech Engineering, Xinzhou Marine Biological Products, Nu-Mega(Clover), Skuny Bioscience, Renpu Pharmaceuticals, Polaris, Solutex µîÀÌ ÀÖÀ¸¸ç, 2024³â ¼¼°è ÁÖ¿ä 5°³ ±â¾÷ÀÇ ¸ÅÃâ Á¡À¯À²Àº ¾à 45.28%¿´½À´Ï´Ù.

»ý»ê Ãø¸é¿¡¼­´Â 2020³âºÎÅÍ 2024³â±îÁö, ±×¸®°í 2031³â±îÁö ¿¹ÃøÇÏ¿© Çǽ¬¿ÀÀÏ EPA ¹× DHAÀÇ »ý»ê·®, ¼ºÀå·ü, Á¦Á¶¾÷üº° ½ÃÀå Á¡À¯À², Áö¿ªº° ½ÃÀå Á¡À¯À²(Áö¿ª ¹× ±¹°¡º°)À» Á¶»çÇϰí ÀÖ½À´Ï´Ù.

¼Òºñ Ãø¸é¿¡¼­´Â Áö¿ª(Áö¿ª ¼öÁØ, ±¹°¡ ¼öÁØ), ±â¾÷º°, À¯Çüº°, ¿ëµµº° Çǽ¬ ¿ÀÀÏ EPA ¹× DHAÀÇ ÆÇ¸Å·®¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è Çǽ¬¿ÀÀÏ EPA ¹× DHA ½ÃÀå °³¿ä, ¿ë·®, »ý»ê·®, ¸ÅÃâ, °¡°Ý ¹× ½ÃÀå ±Ô¸ð¸¦ Á¦½ÃÇÕ´Ï´Ù. ¼¼°è ½ÃÀå µ¿ÇâÀ» ºÐ¼®Çϰí, 2020-2024³â °ú°Å ½ÃÀå ¼öÀÍ ¹× ¸ÅÃâ µ¥ÀÌÅÍ, 2024³â ÃßÁ¤ ¹× ¿¹Ãø, 2031³â±îÁöÀÇ CAGRÀ» ¿¹ÃøÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â Çǽ¬ ¿ÀÀÏ EPA ¹× DHAÀÇ ÁÖ¿ä »ý»êÀÚ¸¦ Á¶»çÇϰí ÁÖ¿ä Áö¿ª ¹× ±¹°¡º° ¼Òºñ·®À» Á¦°øÇÕ´Ï´Ù. Çǽ¬ ¿ÀÀÏ EPA ¹× DHAÀÇ ÇâÈÄ ½ÃÀå ÀáÀç·Â°ú ÀÌ ½ÃÀåÀ» ´Ù¾çÇÑ ºÎ¹® ¹× ÇÏÀ§ ºÎ¹®À¸·Î ¿¹ÃøÇϱâ À§ÇØ ÁÖ¿ä Áö¿ª/±¹°¡¿¡ ÃÊÁ¡À» ¸ÂÃá ÁÖ¿ä Áö¿ª/±¹°¡¿¡ ´ëÇÑ ÇÏÀ̶óÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ, ºê¶óÁú, Áß±¹, ÀϺ», Çѱ¹, µ¿³²¾Æ½Ã¾Æ, Àεµ, µ¶ÀÏ, ¿µ±¹, ÀÌÅ»¸®¾Æ, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ±âŸ ±¹°¡ÀÇ ±¹°¡º° µ¥ÀÌÅÍ ¹× ½ÃÀå °¡Ä¡ ºÐ¼®À» ¿ä¾àÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â 2020³âºÎÅÍ 2024³â±îÁöÀÇ µ¥ÀÌÅ͸¦ ÅëÇØ Çǽ¬ ¿ÀÀÏ EPA ¹× DHAÀÇ ¸ÅÃâ, ¼öÀÍ, ½ÃÀå Á¡À¯À² ¹× ÁÖ¿ä Á¦Á¶¾÷üÀÇ ¾÷°è ¼øÀ§¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. ¼¼°è Çǽ¬ ¿ÀÀÏ EPA ¹× DHA ½ÃÀåÀÇ ÁÖ¿ä ÀÌÇØ°ü°èÀÚ ½Äº°, ÃÖ±Ù µ¿Çâ ¹× ºÎ¹®º° ¼öÀÍ¿¡ ±â¹ÝÇÑ °æÀï ȯ°æ ¹× ½ÃÀå Æ÷Áö¼Å´× ºÐ¼®. ÀÌ º¸°í¼­´Â ÀÌÇØ °ü°èÀÚ°¡ °æÀï »óȲÀ» ÀÌÇØÇÏ°í ´õ ¸¹Àº ÀλçÀÌÆ®¸¦ ¾ò°í ºñÁî´Ï½º ¹× ½ÃÀå Àü·«À» ´õ ³ªÀº ¹æ½ÄÀ¸·Î Æ÷Áö¼Å´×ÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù.

ÀÌ º¸°í¼­´Â 2020³âºÎÅÍ 2031³â±îÁö À¯Çüº°, ¿ëµµº°, Áö¿ªº° ºÎ¹® µ¥ÀÌÅÍ, ¸ÅÃâ, ¼öÀÍ, °¡°ÝÀ» ºÐ¼®ÇÕ´Ï´Ù. Çǽ¬ ¿ÀÀÏ EPA ¹× DHAÀÇ ¸ÅÃâ, ¿¹Ãø ¼ºÀå µ¿Çâ, »ý»ê ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ »ê¾÷ Æò°¡ ¹× ½ÃÀå ±Ô¸ð ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¿¬±¸ ´ë»ó ¹üÀ§

Á¦2Àå ¼¼°èÀÇ Çǽ¬ ¿ÀÀÏ EPA ¹× DHA »ý»ê

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå Á¦Á¶¾÷ü¿¡ ÀÇÇÑ °æÀï

Á¦5Àå À¯Çüº° ½ÃÀå ±Ô¸ð

Á¦6Àå ¿ëµµº° ½ÃÀå ±Ô¸ð

Á¦7Àå ¹Ì±¹¡¤Ä³³ª´Ù

Á¦8Àå À¯·´

Á¦9Àå Áß±¹

Á¦10Àå ¾Æ½Ã¾Æ(Áß±¹ Á¦¿Ü)

Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä«

Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦13Àå ±â¾÷ °³¿ä

Á¦14Àå »ê¾÷ üÀΰú ÆÇ¸Å ä³Î ºÐ¼®

Á¦15Àå Çǽ¬ ¿ÀÀÏ EPA ¹× DHA ½ÃÀå ¿ªÇÐ

Á¦16Àå ¼¼°èÀÇ Çǽ¬ ¿ÀÀÏ EPA ¹× DHA Á¶»çÀÇ ÁÖ¿ä °á°ú

Á¦17Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global Fish Oil EPA and DHA market is projected to grow from US$ 1,624.90 million in 2024 to US$ 2,020.84 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.37% during the forecast period (2025-2031).

The US & Canada market for Fish Oil EPA and DHA is estimated to increase from US$ 585.45 million in 2024 to reach US$ 683.37 million by 2031, at a CAGR of 2.57% during the forecast period of 2025 through 2031.

The China market for Fish Oil EPA and DHA is estimated to increase from US$ 373.56 million in 2024 to reach US$ 524.95 million by 2031, at a CAGR of 5.03% during the forecast period of 2025 through 2031.

The Europe market for Fish Oil EPA and DHA is estimated to increase from US$ 358.13 million in 2024 to reach US$ 428.79 million by 2031, at a CAGR of 2.80% during the forecast period of 2025 through 2031.

The global key manufacturers of Fish Oil EPA and DHA include KD Pharma, Croda, BASF, Yuwang Pharma, GC Rieber VivoMega, Pelagia (EPAX), Golden Omega, TASA, KinOmega Biopharm, Omega Protein, Huatai Phrama, AlaskOmega (Wiley Companies), Jiangsu Auqi Marine Biotechnology, Sinomega Biotech Engineering, Xinzhou Marine Biological Products, Nu-Mega (Clover), Skuny Bioscience, Renpu Pharmaceuticals, Polaris, Solutex, etc. In 2024, the global top five players had a share approximately 45.28% in terms of revenue.

In terms of production side, this report researches the Fish Oil EPA and DHA production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2024, and forecast to 2031.

In terms of consumption side, this report focuses on the sales of Fish Oil EPA and DHA by region (region level and country level), by company, by Type and by Application. from 2020 to 2024 and forecast to 2031.

This report presents an overview of global market for Fish Oil EPA and DHA, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2024, estimates for 2024, and projections of CAGR through 2031.

This report researches the key producers of Fish Oil EPA and DHA, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Fish Oil EPA and DHA, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Fish Oil EPA and DHA sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2024. Identification of the major stakeholders in the global Fish Oil EPA and DHA market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Fish Oil EPA and DHA sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including KD Pharma, Croda, BASF, Yuwang Pharma, GC Rieber VivoMega, Pelagia (EPAX), Golden Omega, TASA, KinOmega Biopharm, Omega Protein, Huatai Phrama, AlaskOmega (Wiley Companies), Jiangsu Auqi Marine Biotechnology, Sinomega Biotech Engineering, Xinzhou Marine Biological Products, Nu-Mega (Clover), Skuny Bioscience, Renpu Pharmaceuticals, Polaris, Solutex, etc.

Market Segmentation

By Company

Segment by Type

Segment by Application

Production by Region

Sales by Region

US & Canada

China

Asia (excluding China)

Europe

Latin America

Middle East and Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Fish Oil EPA and DHA production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Fish Oil EPA and DHA in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Fish Oil EPA and DHA manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.

Chapter 13: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fish Oil EPA and DHA sales, revenue, price, gross margin, and recent development, etc.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 16: The main points and conclusions of the report.

Table of Contents

1 Study Coverage

2 Global Fish Oil EPA and DHA Production

3 Executive Summary

4 Competition by Manufacturers

5 Market Size by Type

6 Market Size by Application

7 US & Canada

8 Europe

9 China

10 Asia (excluding China)

11 Latin America

12 Middle East and Africa

13 Corporate Profile

14 Industry Chain and Sales Channels Analysis

15 Fish Oil EPA and DHA Market Dynamics

16 Key Findings in the Global Fish Oil EPA and DHA Study

17 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â